Personalized Gene Therapy Treatment Market Expansion Is Opening New Pathways For Strategic Investment
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Personalized Gene Therapy Treatment Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The personalized gene therapy treatment sector has experienced rapid expansion in recent years. Its valuation is projected to rise from $8.38 billion in 2025 to $10.11 billion in 2026, reflecting a compound annual growth rate (CAGR) of 20.7%. This historical growth has been driven by a rising incidence of genetic disorders, breakthroughs in genomic sequencing technologies, initial positive outcomes from targeted gene therapies in clinical trials, a growing number of dedicated gene therapy research facilities, and heightened funding directed toward precision medicine.
The personalized gene therapy treatment market is projected to experience robust expansion moving forward. By 2030, it is expected to reach a valuation of $21.23 billion, reflecting a compound annual growth rate (CAGR) of 20.4%. This forecasted growth is driven by a surge in regulatory approvals for tailored gene therapies, a growing need for customized cancer treatments, improved capacity in gene therapy production, heightened incorporation of artificial intelligence into therapy design, and a greater reliance on pharmacogenomics-guided approaches. Key developments shaping this period involve a rising preference for gene editing methods, more widespread use of individualized treatment plans, stronger connections with companion diagnostics, progress in both viral and non-viral vector technologies, and a sharper emphasis on precision oncology uses.
Download A Free Sample Report For Comprehensive Market Insights:
Personalized Gene Therapy Treatment Market Demand Drivers: What Is Fueling Industry Growth?
An anticipated driver for the personalized gene therapy treatment market is the increasing frequency of genetic disorders. These illnesses stem from DNA irregularities that interfere with normal physiological processes. This rise is attributed to advancing parental age, as older reproductive cells carry a heightened risk of passing mutations to offspring. By precisely repairing the defective genes responsible for such conditions and tailoring therapy to an individual’s unique genetic blueprint, personalized gene therapy boosts effectiveness while lowering side effects. For example, according to the Cystic Fibrosis Trust—a UK-based charity—in October 2024 reported that registered cystic fibrosis patients numbered around 11,148 in 2022 and grew to 11,318 in 2023, marking a 1.5% annual increase. Thus, the expanding occurrence of genetic disorders is propelling growth in the personalized gene therapy treatment market.
Personalized Gene Therapy Treatment Market Segment Outlook: Which Categories Are Expanding The Fastest?
The personalized gene therapy treatment market covered in this report is segmented –
1) By Therapy: Targeted Treatments, Pharmacogenomics
2) By Vector Type: Viral, Non-Viral
3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels
4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications
Subsegments:
1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction
Personalized Gene Therapy Treatment Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading players in the personalized gene therapy treatment market are increasingly pursuing strategic partnerships to enhance their technological capabilities and accelerate the delivery of novel therapies to patients. These strategic partnerships represent cooperative arrangements where organizations combine their distinct strengths and resources to achieve mutual growth and competitive advantage, while also distributing associated risks and rewards. A notable example occurred in May 2025, when Aldevron, a US-based manufacturer of DNA, RNA, and proteins, partnered with Integrated DNA Technologies, a US supplier of genomics solutions, to produce the inaugural mRNA-driven personalized CRISPR therapy designed for an infant suffering from a rare, life-threatening genetic disorder known as urea cycle disorder (UCD). This bespoke N of 1 therapy was created and administered within a six-month timeframe, utilizing a custom guide RNA, an mRNA-encoded base editor, off-target safety protocols, and a clinically validated lipid nanoparticle delivery system. The creation of this therapy represents a groundbreaking achievement in the field of personalized in vivo base-editing treatments.
Personalized Gene Therapy Treatment Market Key Companies And Competitive Benchmarking
Major companies operating in the personalized gene therapy treatment market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation
Access The Complete Personalized Gene Therapy Treatment Market Report:
Personalized Gene Therapy Treatment Market Largest Region By Revenue And Market Share
North America was the largest region in the personalized gene therapy treatment market in 2025. The regions covered in the personalized gene therapy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
